Clinical Trial Update: Study to Evaluate the Potential Effect of Benralizumab on the Humoral Immune Response to the Seasonal Influenza Vaccination in Adolescent and Young Adult Patients With Severe Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial assessing whether benralizumab affects the humoral immune response to seasonal influenza vaccination in adolescents and young adults with severe a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Benralizumab (benralizumab)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2018-03-01